Justin Bowers
Stock Analyst at Deutsche Bank
(2.66)
# 2,081
Out of 4,711 analysts
49
Total ratings
42.42%
Success rate
6.52%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $368.16 | -11.72% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $197.27 | +34.33% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $19.26 | +19.42% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $20.03 | +44.78% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $84.47 | +19.57% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $337.28 | -0.38% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $14.04 | +78.06% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $144.46 | +7.30% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $600 → $610 | $524.05 | +16.40% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $73.17 | +12.07% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $21.21 | +17.87% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $5.37 | +216.57% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $207.51 | +44.57% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $228.55 | +20.32% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $331.40 | -24.56% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $185.77 | +56.11% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $19.06 | +141.34% | 5 | May 10, 2021 |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $368.16
Upside: -11.72%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $197.27
Upside: +34.33%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $19.26
Upside: +19.42%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $20.03
Upside: +44.78%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $84.47
Upside: +19.57%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $337.28
Upside: -0.38%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $14.04
Upside: +78.06%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $144.46
Upside: +7.30%
Thermo Fisher
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $524.05
Upside: +16.40%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $73.17
Upside: +12.07%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $21.21
Upside: +17.87%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $5.37
Upside: +216.57%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $207.51
Upside: +44.57%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $228.55
Upside: +20.32%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $331.40
Upside: -24.56%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $185.77
Upside: +56.11%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $19.06
Upside: +141.34%